Difference between revisions of "ICRP Glossary"
Jump to navigation
Jump to search
| Line 729: | Line 729: | ||
*[[Mass median diameter]] | *[[Mass median diameter]] | ||
| + | |||
| + | *MDCT (see [[Multi-detector computed tomography]]) | ||
| + | |||
| + | *[[Mean glandular dose]] | ||
*[[Measured quantity]] | *[[Measured quantity]] | ||
| Line 741: | Line 745: | ||
*MMD (see *[[Mass median diameter]]) | *MMD (see *[[Mass median diameter]]) | ||
| + | |||
| + | *[[Molecular imaging]] | ||
| + | |||
| + | *[[Multifactorial diseases]] | ||
*[[Multiplicative risk projection model]] | *[[Multiplicative risk projection model]] | ||
| Line 747: | Line 755: | ||
*[[Multistage tumorigenesis]] | *[[Multistage tumorigenesis]] | ||
| + | |||
| + | *[[Multitarget equation]] | ||
| + | |||
| + | *[[Multi-detector computed tomography]] | ||
*[[Mutation component]] | *[[Mutation component]] | ||
| Line 755: | Line 767: | ||
=== <big><span id="N">N</span></big> === | === <big><span id="N">N</span></big> === | ||
| + | |||
| + | *[[National DRL]] | ||
*[[Naturally occurring radioactive material]] | *[[Naturally occurring radioactive material]] | ||
| Line 765: | Line 779: | ||
*NHEJ (see [[Non-homologous end joining]]) | *NHEJ (see [[Non-homologous end joining]]) | ||
| + | |||
| + | *[[Noise]] | ||
*[[Nominal risk coefficient]] | *[[Nominal risk coefficient]] | ||
| + | |||
| + | *[[Non-cancer diseases]] | ||
*[[Non-homologous end joining]] | *[[Non-homologous end joining]] | ||
| Line 777: | Line 795: | ||
*[[Normal tissue complication probability]] | *[[Normal tissue complication probability]] | ||
| + | |||
| + | *[[Notification value]] | ||
| + | |||
| + | *[[Nuclear medicine]] | ||
*[[Nuclear track detectors]] | *[[Nuclear track detectors]] | ||
=== <big><span id="O">O</span></big> === | === <big><span id="O">O</span></big> === | ||
| + | |||
| + | *OAR (see [[Organ at risk]]) | ||
*[[Occupancy factor]] | *[[Occupancy factor]] | ||
*[[Occupational exposure]] | *[[Occupational exposure]] | ||
| + | |||
| + | *OEA (see [[Oxygen enhancement ratio]]) | ||
*[[OLINDA/EXM]] | *[[OLINDA/EXM]] | ||
| Line 792: | Line 818: | ||
*[[Optimisation]] | *[[Optimisation]] | ||
| − | *[[Organ/tissue absorbed dose]] | + | *[[Organ absorbed dose]] (see [[Organ/tissue absorbed dose]]) |
| − | *[[Organ | + | *[[Organ at risk]] |
*[[Organ dose equivalent]] | *[[Organ dose equivalent]] | ||
| + | |||
| + | *[[Organ/tissue absorbed dose]] | ||
*[[Other (systemic) tissues]] | *[[Other (systemic) tissues]] | ||
| Line 803: | Line 831: | ||
*[[Oversight]] | *[[Oversight]] | ||
| + | |||
| + | *[[Oxygen enhancement ratio]] | ||
=== <big><span id="P">P</span></big> === | === <big><span id="P">P</span></big> === | ||
Revision as of 15:36, 28 March 2021
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. Some entries include historical descriptions to help readers better understand the term in a particular context.
It is a living document, updated regularly.
Many ICRP publications feature their own glossaries including, for example, highly specialized terms relevant to that specific publication or helpful for a reader to have close at hand, or when introducing new terms to be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ... |
A
- Acute radiation sickness (see Acute radiation syndrome)
- ALI (see Annual limit on intake)
- AMAD (see Activity median aerodynamic diameter)
- Ambient dose equivalent, H*(10)
- ARS (see Acute radiation syndrome)
B
- BAT (see Best available techniques)
- Bcr/abl (see Breakpoint cluster region/abelson)
C
- CACA (see Cobblestone area forming cell assay)
- CAFC (see Cobblestone area forming cell assay)
- CBCT (see Cone beam computed tomography)
- Cobblestone area cell assay (see Cobblestone area forming cell assay)
D
- DAC (see Derived air concentration)
- DD (see Doubling dose)
- DDI, detector dose indicator (see Exposure index)
- DIL (see Derived investigation level)
- DDREF (see Dose and dose-rate effectiveness factor)
- Detector dose indicator (see Exposure index)
- Directional dose equivalent H’(d,Ω)
- DLP (see Dose-length product)
- Dose (of ionising radiation)
- DQE (see Detector quantum efficiency)
- DRL (see Diagnostic reference level)
E
- EAR (see Excess absolute risk)
- EI (see Exposure index)
- ELR (i.e. Excess Lifetime Risk, see Lifetime risk estimates)
- Endosteal tissue (see Endosteum)
- ERR (see Excess relative risk)
- Excess lifetime risk (see Lifetime risk estimates)
F
- Fluence, Φ
- FSU (see Functional subunits)
G
- GATA-2 (see GATA binding protein 2)
- Gray (Gy)
H
- HATM (see Human Alimentary Tract Model]
I
- IMRT (see Intensity-modulated radiotherapy)
- Incidence rate (see Incidence)
J
K
- Kerma, K
L
- LET (see *Linear energy transfer)
- LLE (see Lifetime risk estimates)
- Loss of Life Expectancy (see Lifetime risk estimates)
- LSS (see Life Span Study)
M
- MDCT (see Multi-detector computed tomography)
- MMD (see *Mass median diameter)
N
- NHEJ (see Non-homologous end joining)
O
- OAR (see Organ at risk)
- OEA (see Oxygen enhancement ratio)
P
- Particle fluence (see Fluence)
- Personal dose equivalent, Hp(d)
- PLDR (see Potentially lethal damage repair)
Q
- Quality factor, Q(L)
R
- Radiation detriment (see Detriment)
- RAP (see Reference Animal and Plant)
- RBE (see Relative biological effectiveness)
- Reference female (see Reference Individual)
- Reference male (see Reference Individual)
- REID (see Lifetime risk estimates)
- Response function (see Dose-response function)
- Risk of exposure-induced death (see (see Lifetime risk estimates)
- ROS (see Reactive oxygen species)
- RR (see Relative risk)
S
- S coefficient (radiation weighted) SW[(rT←rs)]
- SAF (see Specific absorbed fraction)
- SEE (see Specific effective energy]
- Sievert (Sv)
- SLDR (see Sublethal damage repair)
- Source (see Radiation source)
T
- Transport of risk (see Transfer of risk)
U
V
W
- wT (see Tissue weighting factor)
- wR (see Radiation weighting factor)
X
Y
Z
...
- α/β ratio (see α/β value)
